what is the glp-1 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response How long should you take
Description
The cohort comprised patients over 20 years old who were newly treated with glucose-lowering drugs between 1 January 2013 and 31 December 2021, and followed until 30 September 2022
Struggling with stubborn weight
Learn about the link between semaglutide, tirzepatide, and gallstone risk, including symptoms to watch for, who faces higher risk, and what to do if complications arise.
Vertigo and dizziness can occur during GLP-1 therapy, but they are not among the most common reported side effects
Based on these findings, we anticipate that women will continue to be disproportionately impacted by the adverse effects associated with all members of this drug class
